GlassScriptPhysician profile
Noa Rivka Schwartz
NPI 1982105516
$7,464.02
in general payments reported to CMS, 2019-2025
43 companies · $895 in 2025
The $895 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,020 · 2022: $2,029 · 2023: $1,855 · 2024: $665 · 2025: $895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,320 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,320.28 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,295.93 | 2021-2025 | |
| Novo Nordisk INC | $1,243.18 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $431.12 | 2021-2025 | Evenity, Prolia, Prolia |
| Glaxosmithkline, LLC. | $421.92 | 2021-2025 | Arexvy, Benlysta, Shingrix |
| Horizon Therapeutics Plc | $375.00 | 2021-2023 | Uplizna, Krystexxa |
| Janssen Scientific Affairs, LLC | $369.98 | 2022-2023 | Tremfya |
| Lilly USA, LLC | $303.58 | 2021-2025 | Mounjaro, Zepbound |
| Teva Pharmaceuticals USA, INC. | $245.55 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $236.53 | 2021-2025 | |
| Astellas Pharma US INC | $222.64 | 2023-2025 | Veozah |
| Abbott Laboratories | $217.10 | 2021-2024 | Freestyle Libre 3, Proclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $214.29 | 2022-2025 | Jardiance, Synjardy, Glyxambi |
| Astrazeneca Pharmaceuticals LP | $203.97 | 2021-2025 | Airsupra |
| Almatica Pharma LLC | $198.92 | 2021-2024 | Loreev Xr, Sertraline Hcl |
| Pfizer INC. | $186.73 | 2021-2025 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noa Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.